China's Innovent Biologics signs drug deal with Pfizer worth up to $10.5bn
--------------------------------------------------------------------
Source: Nikkei Asia
Published: 2026-05-29 12:09 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Property, Asia, China, Drugs, Business & Economy, Asia Pacific
--------------------------------------------------------------------
Snippet:
Innovent Biologics and Pfizer plan to collaborate on licensing, co-development and co-commercialization for 12 oncology programs. (Source photos by Reuters and Getty Images)
--------------------------------------------------------------------